U.S. insulin costs per patient nearly doubled from 2012 to 2016 - study

By Robin Respaut and Chad Terhune (Reuters) - The cost of insulin for treating type 1 diabetes in the United States nearly doubled over a five-year period, underscoring a national outcry over rising drug prices, according to a new analysis shared with Reuters. A person with type 1 diabetes incurred annual insulin costs of $5,705, on average, in 2016

from Latest News World on Firstpost http://bit.ly/2AZ7xsi